Key details on Seattle Genetics (Ticker: SGEN)
- CUSIP: 812578102
- Is SGEN overvalued or undervalued? Run a discounted cash flow (DCF) valuation analysis on SGEN
Who owns Seattle Genetics?
Is SGEN a good stock to own? Find out who bought Seattle Genetics, who sold Seattle Genetics (SGEN) stock, and who holds a large position in Seattle Genetics.
|Fund Name||Number of Shares||Share Valuation||As Of|
|Baker Bros. Advisors||28.88M||$1.02B||March 31, 2015|
|FMR||18.72M||$906.27M||June 30, 2015|
|BAILLIE GIFFORD & CO||15.16M||$733.81M||June 30, 2015|
|PRIMECAP Management Company||11.90M||$575.92M||June 30, 2015|
|Vanguard||6.23M||$301.54M||June 30, 2015|
|Capital Guardian Trust Company||5.18M||$197.97M||June 30, 2014|
|Columbia Wanger Asset Management||3.41M||$120.48M||March 31, 2015|
|First Trust Advisors||3.22M||$155.67M||June 30, 2015|
|Daniel D. Thurber||3.03M||$146.85M||June 30, 2015|
|Wellington Management Company||2.95M||$134.56M||March 31, 2014|
|STATE STREET CORPORATION||2.71M||$62.97M||Dec. 31, 2013|
|T. Rowe Price Associates||2.69M||$95.08M||March 31, 2015|
|BlackRock Fund Advisors||2.56M||$124.03M||June 30, 2015|
|BlackRock Institutional Trust Company, N.A.||2.55M||$90.01M||March 31, 2015|
Who sold Seattle Genetics?
|Fund Name||Date Sold||Number of Shares Sold||Share Valuation|
|Bill & Melinda Gates Foundation Trust||June 30, 2009||3.02M||$29.36M|